Glycation of H1 Histone by 3-Deoxyglucosone: Effects on Protein Structure and Generation of Different Advanced Glycation End Products

PLoS One. 2015 Jun 29;10(6):e0130630. doi: 10.1371/journal.pone.0130630. eCollection 2015.

Abstract

Advanced glycation end products (AGEs) culminate from the non-enzymatic reaction between a free carbonyl group of a reducing sugar and free amino group of proteins. 3-deoxyglucosone (3-DG) is one of the dicarbonyl species that rapidly forms several protein-AGE complexes that are believed to be involved in the pathogenesis of several diseases, particularly diabetic complications. In this study, the generation of AGEs (Nε-carboxymethyl lysine and pentosidine) by 3-DG in H1 histone protein was characterized by evaluating extent of side chain modification (lysine and arginine) and formation of Amadori products as well as carbonyl contents using several physicochemical techniques. Results strongly suggested that 3-DG is a potent glycating agent that forms various intermediates and AGEs during glycation reactions and affects the secondary structure of the H1 protein. Structural changes and AGE formation may influence the function of H1 histone and compromise chromatin structures in cases of secondary diabetic complications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cattle
  • Chromatography, High Pressure Liquid
  • Circular Dichroism
  • Deoxyglucose / analogs & derivatives*
  • Deoxyglucose / pharmacology
  • Enzyme-Linked Immunosorbent Assay
  • Glycation End Products, Advanced / metabolism*
  • Glycosylation / drug effects
  • Histones / chemistry*
  • Histones / metabolism*
  • Protein Denaturation / drug effects
  • Spectrophotometry, Ultraviolet
  • Spectroscopy, Fourier Transform Infrared
  • Temperature

Substances

  • Glycation End Products, Advanced
  • Histones
  • Deoxyglucose
  • 3-deoxyglucosone

Grants and funding

This study was supported by a National Research Foundation of Korea grant funded by the Republic of Korea government (MSIP; no. 2014R1A2A2A01006324).